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ABSTRACT
In the last few decades, a number of probabilistic mod-
els for drug delivery have been developed. Of particu-
lar interest are those that model controlled release sys-
tems to provide targeted dose delivery. Controlled re-
lease is achieved by using polymers with different disso-
lution characteristics. We present here a model based
on Monte Carlo and Cellular Automata approaches, for
simulating drug release from coated microspheres in the
gastro-intestinal tract. Controlled release is obtained us-
ing ethylcellulose as the coating polymer. Modelling fea-
tures, such as the drug and coating dissolution are non-
trivial, since material is non-homogenously dispersed
and the dissolution exhibits complex behaviour. Im-
portant underlying mechanisms of the process, such as
erosion, are described here.
INTRODUCTION
Drug delivery systems (DDS) are pharmaceutical sys-
tems designed for transporting drugs into the body. The
computational modelling of DDS is a constantly devel-
oping field, with the potential to become an integral
part of pharmaceutical research, as some modern drug
formulations are very complex and the influence of sys-
tem composition and variables on the release profiles is
not fully understood. In-silico modelling of DDS can,
therefore, be of benefit in reducing the cost of experi-
ments, (involving large amount of in vitro testing), as
well as length of time needed to introduce the drug to
the market. Controlled drug delivery systems are a type
of DDS, the primary objective of which is to deliver drug
at the desired rate to a targeted site in the body. Con-
trol is maintained by using polymers of different struc-
tures. Consequently, polymer dissolution is one of the
most important problems to solve in achieving this type
of release.
Here, we present a probabilistic model based on Monte
Carlo (MC) and Cellular Automata (CA) approaches,
for simulating controlled release from coated micro-
spheres. The work is rooted in an ongoing industrial col-
laboration and aims to address the release problem for
the drug (cyclosporine) in targeting the gastro-intestinal
(GI) tract. As one of a number of suitable coating mate-
rials, we model the use of ethylcellulose (EC), a generally
non-invasive polymer with good film-forming capabili-
ties. It is both an inert and hydrophobic polymer but,
when maintained under high humidity, can absorb water
in large amounts (Geraghty 2004). In general, properties
of ethylcellulose make it ideal for use in matrix agents,
for prolonged release, or as a coating material.
THEORY
The first step in modelling the dissolution is to deter-
mine the in vitro dissolution rate under various external
conditions, as measured in the dissolution test appara-
tus. Standard test methods for measuring those rates
are outlined in the pharmacopoeias (European Pharma-
copoeia, United States Pharmacopoeia). Here, we used
the paddle apparatus II, (USP II), which allows us to
mimic metabolic conditions, such as change of temper-
ature, type of solution (pH and dynamic flux of the
solution), by varying speed of the paddle, and monitor
experimentally their influence on the drug dissolution
rate.
Theoretical models will vary according to the type and
complexity of the system, and can be used to explore
experimental in vitro data. Theories are generally di-
vided into three broad groups: mechanistic, empirical
and probabilistic (Siepmann and Siepmann 2008). The
first two groups take the top-down approach, start from
known parameters and use specific deterministic release
rate equations for each individual problem, (i.e. to rep-
resent physical laws and empirical information). The
most important properties must be either known from
the manufacturing process or be possible to calculate,
which is not straightforward given the complex nature
of the formulations. Conversely, for complex detail mod-
elling, bottom-up theories, (incorporating stochastic as-
sumptions), have the potential to yield better predic-
tions while requiring less initial information. These sim-
ulate release curves by observing the probabilistic be-
haviour of individual particles and have the advantage
of providing a simplified representation of the system,
Figure 1: Simplified Internal Morphology of one 3D
Sphere Simulating Drug Dissolution through Coating
Layer (Ethylcellulose). Enlarged: Part of the Sphere
with Definition of Model Cell Types
Figure 2: Simulation Stages: Initial Stage (left), Dur-
ing Release, with Gelatine (centre), After all Gelatine is
Dissolved (right)
(Barat et al. 2008b).
Monte Carlo methods have numerous applications,
ranging from fluid dynamics, space and traffic modelling
and statistical physics, to financial analysis (Li et al.
2007, Sopasakis 2004, Tezuka et al. 2005). In one of the
first direct MC models of DDS, microstructural changes
in bioerodible polymers were simulated (Go¨pferich and
Langer 1993). MC is also often used as a framework
for Cellular Automata movement. In a CA system, a
discrete grid of individual cells is defined, where each
cell can have one of a number of defined states. The
behaviour of each cell is governed by a set of rules that
describe the local state transitions over discrete time
steps, (Zygourakis 1990).
Drug Dissolution Phenomena
Important phenomena in polymeric drug delivery sys-
tems include: (i) diffusion: the motion of molecules from
a region of higher to one of lower concentration i.e. flux.
In the modelling of DDS, diffusion is often described by
Fick’s laws, (Crank 1975). In one dimension, Fick’s first
Figure 3: Release Profiles as a Function of the Degra-
dation Rate Lambda (λ)
law can be represented as:
J = −D δc
δx
(1)
where J is the diffusion flux, D is the diffusion coefficient
and c is the concentration; (ii) degradation: the process
whereby chain scission occurs causing polymer chains to
become oligomers and monomers, facilitating easy re-
lease. Degradation is the first step of erosion (Go¨pferich
1996); (iii) erosion: the loss of material from a polymer
due to degradation. It determines the release rate of the
drug (Siepmann and Go¨pferich 2001). When a polymer
erodes it leaves space for the drug to be released from the
compact, or for water penetration. Two types of erosion
are defined (Langer and Peppas 1983): Surface erosion is
a homogeneous process and represents the stage during
which the size of the compact decreases while the shape
remains constant; the compact loses material only from
its surface; Bulk erosion is a heterogeneous process with
material being lost from the whole compact, although
the size remains constant.
MODEL FEATURES
In a previous project (Barat et al. 2008a), (Barat et al.
2008b), microspheres filled with polylactic-co-glycolic
acid (PLGA) polymer were modelled. In these, drug
is homogeneously dispersed throughout the sphere and
contained within a polymer. Understanding the phe-
nomena occurring in polymeric spheres was achieved
through dimensional (3D) stochastic Cellular Automata
and agent-based modelling. The rationale for introduc-
ing the agent-basis is simplification of the interaction
of system elements using specifically designed entities
(agents), which have simple properties and character-
istics. The influence of a number of parameters defin-
ing release curves was investigated, including porosity,
drug loading, sphere size and type of neighbourhood,
(Von Neumann or Moore). Some of the earlier results
are illustrated (Figure 3), which show how the sphere
porosity growth dynamics affect the release rate.
Current Work
The modelled device now consists of a drug, non-
homogenously dispersed in a coated sphere, where the
coating predominantly controls the rate of drug release.
The aim of the model is to determine how different prop-
erties of the device, such as coating thickness or size of
the sphere, affect the release rates. Monte Carlo and
Cellular Automata methods are used to describe the
system in terms of a 3D grid of cells, with erosion and
diffusion as the main release mechanisms. This discrete
approach is preferred over a continuous one, (used in
mechanistic theories), due to straightforward mimick-
ing of the real system which is discrete by nature. Each
cell can have one of several possible states, described in
the (Table 1). The state transitions are influenced by
the states of all the cells in the Von Neumann neigh-
bourhood for a 3D matrix (i.e. 26 neighbouring cells).
In its initial state, the drug is taken to be randomly
dispersed in the form of ”packets” inside a gelatinous
sphere, coated by a polymer layer. Diffusion of the drug
inside the sphere is represented as a random walk of drug
packets, influenced by concentration differences between
neighbouring cells. The highest probability for move-
ment will be in the direction of the largest concentration
gradient, based on the Fick’s first law.
Behaviour of coating layer cells is based on work,
(Go¨pferich and Langer 1993), where scission of the poly-
mer chains and formation of pores follows the Erlang
distribution:
e(t) = λteλt, t ≥ 0 (2)
The rate of the pore formation is characterised by λ
which defines the lifetime, t, of an individual EC cell:
t =
1
λ
ln(U) (3)
where U takes randomly distributed values between 0
and 1. When the cell lifetime is reached, the cell is
considered to be eroded, and forms a channel through
which the drug packet can diffuse. This occurs at a
rate slower than the diffusion rate inside the coating,
(solvent cells), reflecting the influence of permeability
of the membrane (Laaksonen et al. 2009). The release
rate is measured by counting the number of packets that
reach the buffer zone, which is assumed to have perfect
sink conditions.
RESULTS AND EXPLANATIONS
The simulation was developed in C++ with OpenGL
used for graphical representation. The matrix size was
Figure 4: Release Profiles as a Function of the Simula-
tion Time Interval
Figure 5: Simulated Release Profiles Against Experi-
mental Release Profiles. Experimental Data Provided
by Sigmoid Pharma Ltd.
Figure 6: Release Profiles as a Function of the Coating
Degradation Rate Lambda
Cell type Behaviour description
Buffer Drug is released when it reaches buffer
zone. Cell type acts as a perfect sink.
Ethyl-
cellulose
Drug-free coating layer. Assigned life-
time based on the λ (degradation rate)
parameter. Forms an EC channel cell
upon complete erosion.
EC-
channel
Gelatine and drug can diffuse through
EC channel cells.
Gelatine Fixed lifetime. During diffusion
through solvent cells, facilitates move-
ment of drug ”packets”.
Solvent Gelatine erodes into the solvent. Drug
can diffuse through the latter.
Drug
packet
Drug, initially dispersed in gelatine
cells. Each cell can hold a maximum
(saturation) amount of drug ”packets”.
Table 1: Set of Cell Types and Rules of Behaviour.
200 x 200 x 200, with cell size being 10µm. The averag-
ing of the values for 24 repeated runs showed a negligible
variation in results for a given set of same parameters.
Model parameters, the effects of which on drug release
rates were studied in this work were: the size of the mi-
crosphere, the erosion rates of gelatine and ethylcellulose
and the effect of coating thickness. The initial values
were set according to the available in vitro data and un-
less otherwise stated, the erosion rates of gelatine and
ethylcellulose are 90 minutes and 2 days, respectively.
The sphere was taken to be 1.43 mm in diameter, and
to contain 5% of EC coating. Drug loading is kept con-
stant for all simulations at 10.8% of the mass.
The first step in modelling was to determine the most
appropriate time interval in which cell states should be
updated. This essential parameter directly determines
the diffusion and has order of magnitude in seconds,
(from Fick’s first law and dimensional analysis). Sim-
ulations were then performed for intervals between 5
seconds and 1 minute, (Figure 4). By comparing results
against experimental data, (Figure 5), a time interval of
5 seconds was chosen for all subsequent simulations.
The effect of porosity in the coating layer was investi-
gated by varying lifetime of EC cells, (i.e. varying λ), to
obtain different release behaviours for different lifetimes
of EC chains, (Figure 6). The slower release rate of the
drug is due to decreased porosity, i.e. slower channel
formation occurring in the coating.
Weight gain of the coating thickness is also one of the
primary factors influencing drug formulation and perfor-
mance. Here, we vary the coating levels from 4% - 8%,
(Figure 7). The produced release curves qualitatively
reproduce reduction in diffusion rate, but the impact
of adjusting the weight gain is somewhat smaller than
experienced in vitro. This is expected, to some extent,
as perfect sink conditions are modelled in this case. In
Figure 7: Release Profiles as a Function of Coating
Weight Gain
Figure 8: Release Profiles as a Function of Gelatine Life-
time
reality, concentration of ethylcellulose in the boundary
layer inhibits movement of drug packets and some local
saturation occurs. This phenomenon must be taken into
account in future model extensions.
As can be seen, (Figure 8), the lifetime of the gelatine
carrier can be considered to be negligible in terms of
influence on final release rate. However, gelatine is an
important controller of the drug release in the initial
stages, as it influences the ”burst effect” by accelerating
drug transfer through EC channels. The size distribu-
tion of microspheres determines the actual mean and
variance of release rate, (Figure 9). This feature sug-
gests refinement of initial parameters is necessary, (e.g.
coating thickness or drug loading), as these are directly
dependent on the size of the sphere. Increasing micro-
sphere size mostly slows down drug release due both
to the capability of the device to hold more drug and
the fact that larger spheres have heavier and thus less
permeable coatings.
Figure 9: Release Profiles as a Function of Sphere Di-
ameter
FUTURE WORK
Although simulated results do not reflect quantitative
in vitro data precisely, (Figure 5), results obtained are
promising. These show that the model predicts qual-
itatively similar behaviour compared to that seen for
experimental release curves. Results also show that the
behaviour of EC cannot be modelled using erosion only,
but that other phenomena, such as swelling, which in-
fluence volume increase due to the increased hydration
of the broken polymer chains, have to be taken into ac-
count (Atyabi et al. 2004). A future focus will thus
be incorporation, into the model, of the swelling effect,
caused by adding additives to the coating structure.
Additionally, the model will be augmented to include
the effect of different polymer coatings and different me-
dia surrounding the drug (biphasic release) in order to
simulate different stages of the GI tract environment.
The deduction of unknown parameters from the exper-
imental release curves using reverse engineering and in-
verse Monte Carlo methods is a long-term aim. Nev-
ertheless, the approach to date enables comparison of
a set of simulated and experimental release curves al-
lowing us to determine key parameters and their values
for this novel formulation and to reproduce qualitative
behaviour. This enables us to compare a large set of
simulated release curves with real ones in order to esti-
mate best fit parameter values.
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